Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid‐refractory graft‐vs‐host disease (GvHD), with a good effect to side effect profile. In …

Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Patients underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) are at
high risk of acquiring tuberculosis (TB) due to a status of immunosuppression. We …

Extracorporeal photopheresis (ECP), a personalized cellular immunotherapy, constitutes a
promising treatment for steroid-refractory/-resistant graft-versus-host disease (SR-GvHD) …

Background Infections are common with significant mortality and morbidity in patients with
graft‐versus‐host disease (GvHD). Extracorporeal photopheresis (ECP) is an advantageous …

These guidelines represent a GRADE-method revision of the recommendations produced
by the Italian Society of Hemapheresis and Cell Manipulation (SIDEM) and the Italian …

Graft-versus-host disease (GVHD), either in its acute or chronic form, is the main contributory
factor for morbidity and non-relapse mortality after allogeneic hematopoietic stem cell …

Background Extracorporeal photopheresis (ECP) is frequently used to treat moderate-
severe chronic graft versus host disease (cGVHD), however limited data exists describing …

Chronic graft-versus-host disease (cGVHD) remains one of the most severe complications
after allogeneic hematopoietic stem cell transplantation (HSCT), affecting both the quality of …

Figure 1 Photo documentation of a 49-year-old female patient prior to ECP (a1–a3), at the
time of the initial objective response after 32 months (36 cycles of ECP; b1–b3) and after 58 …